Table 1 Characteristics of the included studies
Study | Level of evidence | Design | Matchinga | Follow-up (month)f RAPN/OPN | No. of centers | Quality scoreg |
|---|---|---|---|---|---|---|
Wu et al. [10] | IIIb | R | 1,2,3,4,6,8 | 12 (6–24)/12 (6–24) | Single | ☆☆☆☆☆☆☆ |
Vittori et al. [11] | II | PN | 1,2,3,4,7,8 | Perioperative | Multicenter | ☆☆☆☆☆☆ |
Masson-Lecomte et al. [16] | IIIb | RP | 1,2,3,4,6,8 | 19 (6–30)/32 (12–40) | Single | ☆☆☆☆☆☆☆ |
Ficarra et al. [17] | IIIb | R | 1,2,5,6,7,8 | Perioperative | Multicenter | ☆☆☆☆☆☆☆ |
Kim et al. [24] | IV | R | 1,2,3,4,5,6 | NA/NA | NA | ☆☆☆☆ |
Lucas et al. [18] | IIIb | R | 1,2,3,6,7,8,9 | 9.4 ± 7.6/21.1 ± 18.8 | Single | ☆☆☆☆☆☆ |
Han et al. [6] | IIIb | RP | 1,2, 4,5,6,7,8 | Perioperative | Single | ☆☆☆☆☆☆☆ |
Oh et al. [19] | IIIb | R | 1,2,3,4,5,6,7, 8,9 | Perioperative | Single | ☆☆☆☆☆☆☆☆ |
Lee et al. [9] | IV | R | 1,2,5,6,8 | NA/NA | Single | ☆☆☆☆☆ |
Alemozaffar et al. [7] | IIIb | R | 2,3,4,5,6,7 | Perioperative | Single | ☆☆☆☆☆☆ |
Simhan et al. [12] | IIIb | RP | 1,2,3,4,6,7 | 17.1 ± 9.2/23.9 ± 20.5b; 21.3 ± 13.3/19.8 ± 11.1c | Single | ☆☆☆☆☆☆ |
Zargar et al. [20] | IIIb | R | 1,2,3,5,6,7 | 7.8 (18.7)/14 (14.5)d; 4 (18)/19.6 (29.7)e | Multicenter | ☆☆☆☆☆☆ |
Boylu et al. [8] | II | PN | 1,2,3,5,6,8 | 33 ± 13/37 ± 20 | Single | ☆☆☆☆☆☆ |
Mano et al. [22] | IIIb | R | 1,2,3,4,5,6,7 | Perioperative | Single | ☆☆☆☆☆☆ |
Miyake et al. [23] | IIIb | R | 1,2,3,4,5,6,7,8 | 1/1 | Single | ☆☆☆☆☆☆ |
Webb et al. [21] | IIIb | R | 1,2,5,6,8 | NA/NA | Single | ☆☆☆☆☆ |